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SCIENTIFIC LETTER
Prevalence and clinical implications of atrial fibrillation
episodes detected by pacemaker in patients with sick sinus
syndrome
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R
ecent prospective clinical trials have demonstrated that
physiologic pacing mode reduces the risk of atrial
fibrillation (AF) compared to single chamber ventricular
pacing in patients with sick sinus syndrome (SSS).1–3
Previous studies have shown that patients with a prior
history of AF before pacemaker implant are associated with
an increase risk of persistent AF.3 Recent advances in the
ability to store diagnostic information in implanted devices
have provided an opportunity for detection and documenta-
tion of AF. The aim of this study was to define the prevalence
and clinical significance of device detected AF episodes in
patients implanted with pacemakers for SSS.
METHODS
We studied the clinical characteristics and long term clinical
outcome in patients with SSS who had received a dual
chamber rate responsive pacemaker (DDDR) for symptomatic
bradycardia in our institutions from 1992 to 1998. Patients
were eligible if they received a DDDR pacemaker which was
capable of providing diagnostic counters for supraventricular
tachyarrhythmias and was programmed ‘‘ON’’. P wave
analysis was manually measured by a single investigator. A
surface echocardiogram was performed in all patients before
implant to assess left atrial size, left ventricular ejection
fraction, and left ventricular mass.
Data were retrospectively collected regarding demographic
characteristics, device diagnostics, clinical status, and out-
come during the follow up period. Clinical data were
retrieved from the medical records and subsequently during
the most recent clinic visit. The following clinical events of
each patient were retrieved from their clinical records: the
time to the first occurrence of AF; the development of
persistent AF; and major cardiovascular events: non-fatal
stroke, hospitalisation for congestive heart failure, or
cardiovascular death. The AF episode was categorised as
either paroxysmal if sinus rhythm was recorded at the
subsequent follow up after an episode of AF, or persistent if it
was recorded at two consecutive follow up visits.
Continuous variables are expressed as mean (1 SD).
Statistical comparisons were performed with Student’s t test
or Fisher’s exact test, as appropriate. Cox regression analysis
was used to examine the clinical predictors of major
cardiovascular events and persistent AF. Actuarial curves
for the incidence of persistent AF and major cardiovascular
events in patients with and without device detected AF
episodes were calculated by the Kaplan-Meier method. A
probability value of p , 0.05 was considered significant.
RESULTS
The clinical characteristics of 226 patients included in this
analysis are shown in table 1. After a mean follow up of 84
(16) months, 99 patients (44%) had at least one AF episode
documented by the pacemaker. In 30/139 (22%) patients
without a prior history of AF, their pacemaker diagnostic
counters detected AF after implant. In 18/87 (21%) patients
with a prior history of AF, their pacemaker diagnostic
counters did not detect any AF after implant. Patients with
device detected AF episodes were more likely to have a
history of AF before pacemaker implant, underlying struc-
tural heart diseases, antiarrhythmic drug treatment and
anticoagulation use, larger left atria, lower left ventricular
ejection fraction and higher prevalence of left ventricular
hypertrophy on echocardiography, and longer P wave
duration than patients without AF (table 1).
Persistent AF developed in 49/226 (22%) patients. Cox
regression analysis demonstrated that a prior history of AF
before pacemaker implantation (hazard ratio (HR) 4.2, 95%
confidence interval (CI) 2.1 to 10.8; p , 0.001) and the
presence of device detected AF episodes (HR 3.1, 95% CI 1.9
to 12.8; p = 0.02) were independent predictors of the
development of persistent AF. Kaplan-Meier analysis
revealed a significantly higher proportion of persistent AF
in patients with a prior history of AF, any device detected AF
episodes, or newly device detected AF episodes compared to
patients without any AF episodes (p , 0.001) (fig 1).
Patients with device detected AF episodes had significantly
higher prevalence of major cardiovascular events and
nonfatal strokes than those without AF episodes
(p , 0.001) (table 1). Cox regression analysis showed that
a prior history of AF before pacemaker implantation (HR 2.4,
95% CI 1.2 to 13.8; p = 0.013) and the presence of device
detected AF episodes (HR 2.0, 95% CI 1.1 to 15.8; p = 0.020)
were independent predictors of major cardiovascular events.
Kaplan-Meier analysis revealed a significantly higher pre-
valence of major cardiovascular events in patients with a
prior history of AF, any device detected AF episodes, or new
device detected AF episodes compared to patients without
any AF episodes (p , 0.05) (fig 1).
DISCUSSION
Previous clinical studies have reported that up to two thirds
of patients with a pacemaker have atrial arrhythmias
detected by the devices.4 However, the clinical significance
of this unexpectedly high incidence of non-sustained device
detected atrial arrhythmias remains unclear. In this study, we
detected AF episodes in 44% of our patients during long term
follow up, and it was associated with a 10 fold increase
in the incidence of persistent AF, and a 2.5-fold increase in
major cardiovascular events, especially stroke. Our results
confirm the finding of a recent study,5 and reveal that the
presence of device detected AF episodes, irrespective of
symptoms, was an independent predictor for persistent AF
and major cardiovascular events. Most importantly, our data
Abbreviations: AF, atrial fibrillation; CI, confidence interval; HR,
hazard ratio; SSS, sick sinus syndrome
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demonstrated the presence of new device detected AF
episodes in 22% patients without a prior history of AF. The
occurrence of AF in those patients was also associated with a
higher incidence of developing persistent AF and major
cardiovascular events during long term follow up. The use of
device detected AF episodes defines a subgroup of patients
who did not have a prior history of AF at higher risk of
developing persistent AF and major cardiovascular events.
Therefore, it is clinically valuable to detect AF episodes in
those patients so that anticoagulation treatment can be
initiated to prevent stroke.
In conclusion, in patients with SSS, AF frequently develops
after DDDR pacemaker implantation, and progresses to
persistent AF over long term follow up. These data suggest
the use of a pacemaker diagnostic counter to detect AF
episodes in pacemaker patients, especially in those without a
prior history of AF, can assist in identifying patients at risk of
developing persistent AF and major cardiovascular events,
especially stroke. Anticoagulation treatment for stroke pre-
vention should be considered in those patients who have a
prior history of AF or device detected AF episodes.
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Extracardiac cause of right ventricular outflow tract obstruction
A
49 year old man was referred to
the cardiology clinic for a loud
systolic murmur. He was an ex-
smoker and had a past history of
thyrotoxicosis for which he had radio-
active iodine treatment followed by
current oral thyroxine replacement. His
co-morbid problems included hyperten-
sion and hyperlipidaemia. He com-
plained of having retrosternal chest
discomfort for two years with a recent
onset of exertional dyspnoea over two
months. In addition, he also had loss of
appetite as well as weight loss over the
past one year. On examination, he was
clinically euthyroid. There was a loud
and harsh ejection systolic murmur
loudest over the left lower sternal edge
with no radiation of the murmur.
A two dimensional echocardiogram
was performed. This revealed a large
mass lesion adjacent to the right ven-
tricle (panel A: Ao, aorta; LA, left
atrium; LV, left ventricle; RV, right
ventricle). Colour flow imaging demon-
strated a mosaic pattern consistent with
that of a turbulent flow across the right
ventricular outflow tract (panels B and
C: AVO, aortic valve orifice; PV, pul-
monary valve; RVOT, right ventricular
outflow tract). The peak Doppler gradi-
ent across the right ventricular outflow
tract was 24 mm Hg (panel D).
A computed tomogram (CT) of the
thorax was performed on the same day.
This showed a heterogenous anterior
mediastinal mass measuring approxi-
mately 86 6 cm which was invading
the pericardium inferiorly (panels E
and F). The mass was distorting the
superior portion of the right ventricle. It
was also displacing the pulmonary
trunk posteriorly. Several lobulated
hypodensities were seen in the right
hepatic lobe and the caudate lobe which
were suggestive of hepatic metastases.
The patient then underwent a CT guided
biopsy of this anterior mediastinal mass.
The histopathology of this mass was
consistent with that of a thymic carci-
noma. He was referred to the oncologist
and chemotherapy was planned as the
modality of treatment for his condition.
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